Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;10(12):3681-7.
doi: 10.4161/21645515.2014.980204.

Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines

Affiliations

Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines

Nguyen V Trang et al. Hum Vaccin Immunother. 2014.

Abstract

Rotavirus (RV) is the most common cause of childhood diarrhea worldwide, and several vaccines have been successfully developed to reduce the burden of disease. However, lower vaccine immunogenicity and efficacy in developing countries might be related to the virus-neutralizing activity of breast milk. We examined possible differences in breast milk antibody levels (total IgA antibody, RV-specific antibodies, and RV-neutralizing antibodies) between healthy mothers living in a rural area (n=145) and mothers living in an urban area (n=147) of Vietnam. Total IgA concentration was significantly higher in samples from mothers in the rural region than in samples from mothers in the urban region, whereas urban mothers had significantly higher RV-specific IgA antibody titers than did rural mothers. Neutralizing antibodies against RV strain G1P[8] were undetected in nearly one-half of the breast milk samples (45-48%), whereas the majority of the remaining samples had low antibody titers (2-16). Despite these low titers, the breast milk still reduced vaccine strain titers (2×10(6) plaque forming units/mL) up to 80% or more, even at a milk-to-virus ratio of 1:8. An increase in neutralizing anti-G1P[8] antibody titers (P<0.05) in rural infants over time suggests a continuous exposure to circulating RV. These results contribute to the understanding of the potential interference of breast milk with RV vaccine efficacy and immunogenicity in Vietnamese infants.

Keywords: DTP, diphtheria–tetanus–pertussis; ELISA, Enzyme linked immunosorbent assay; G1-VN, neutralizing antibodies against G1P[8]; G4-VN, neutralizing antibodies against G4P[6]; HCl, Hydrogen chloride; HRP, Horseradish peroxidase; IgA; IgA, Immunoglobulin A; IgG, Immunoglobulin G; MEM, Minimal essential medium; NIHE, National Institute of Hygiene and Epidemiology; OD, Optical density; P-RV, Rotavirus strain P; PBS, Phosphate-buffered saline; PFU, Plaque-forming unit; POLYVAC, Center for Production of Vaccines and Biologicals; RRV, Rhesus rotavirus; RV, Rotavirus; SE, Standard error;; TMB, 3, 3′, 5, 5′-Tetramethylbenzidine; Vietnam; breast milk; neutralizing antibody; rotavirus.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cumulative frequency profile of (1A) total IgA antibodies (mg/dL) or (1B) RV-specific IgA titers in breast milk of mothers living in a rural (dotted line) or urban (solid line) Vietnamese region.
Figure 2.
Figure 2.
RV-specific IgA titer distribution in breast milk of mothers living in (2A) rural or (2B) urban Vietnamese region, categorized according to infant age group. Six outliners (titers > 1200) have been removed, one in each age group of both rural and urban mothers.
Figure 3.
Figure 3.
Distribution profile of neutralizing titers against (3A) the G1P[8] strain of the Rotavin-M1 vaccine and (3B) G4P[6] strain in breast milk of mothers living in a rural or urban Vietnamese region. Four and 5 outliners (titers > 60) were removed for the G1P[8] Rotavin-M1 and G4P[6] groups, respectively.
Figure 4.
Figure 4.
Correlation between neutralizing activity of breast milk to the Rotavin-M1 vaccine strain (G1P[8]) and the RV-IgA (4A), G1 (4B), and G4-VN (4C) antibody titers measured in the samples.

References

    1. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O'Brien KL, Campbell H, Black RE. Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381:1405-16; PMID:23582727; http://dx.doi.org/10.1016/S0140-6736(13)60222-6 - DOI - PMC - PubMed
    1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41; PMID:22030330; http://dx.doi.org/10.1016/S1473-3099(11)70253-5 - DOI - PubMed
    1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72; PMID:12737740; http://dx.doi.org/10.3201/eid0905.020562 - DOI - PMC - PubMed
    1. Rotavirus vaccines WHO position paper: January 2013 -recommendations. Vaccine 2013; 31:6170-1; PMID:23746456; http://dx.doi.org/10.1016/j.vaccine.2013.05.037 - DOI - PubMed
    1. Anh DD, Thiem VD, Fischer TK, Canh DG, Minh TT, Tho le H, Van Man N, Luan le T, Kilgore P, von Seidlein L, et al. . The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial. Pediatr Infect Dis J 2006; 25:37-40; PMID:16395100; http://dx.doi.org/10.1097/01.inf.0000195635.05186.52 - DOI - PubMed

Publication types